BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6876444)

  • 21. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histology of bronchial carcinoma and regional lymph nodes as putative immune response of the host to the tumor.
    Di Paola M; Bertolotti A; Colizza S; Coli M
    J Thorac Cardiovasc Surg; 1977 Apr; 73(4):531-7. PubMed ID: 839842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer.
    Yuan S; Meng X; Yu J; Mu D; Chao KS; Zhang J; Zhong W; Yu Y; Wang J; Sun X; Yang G; Wang Y
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):727-34. PubMed ID: 17293231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node metastasis of T1, T2 squamous carcinoma and adenocarcinoma of lung: characteristics and clinical significance.
    Li Y; Liu H; Li H; Hu Y; Yin H; Wang Z
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):725-7. PubMed ID: 11832148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between metastatic rate and amount of lymph nodes and prognosis of gastric cancer].
    Li K; Xu HM; Chen JQ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2113-6. PubMed ID: 16313820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is adjuvant chemotherapy necessary for the peripherally located stage I adenocarcinoma of the lung?].
    Ohta S; Hirose M; Ishibashi H; Muro H
    Kyobu Geka; 2007 Jul; 60(7):519-22; discussion 522-5. PubMed ID: 17642210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
    Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
    Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
    Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
    J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stage IB non-small cell lung cancer: impact of the number of lymph nodes examined on survival].
    Cerón J; Peñalver JC; Jordá C; Padilla J
    Arch Bronconeumol; 2009 Feb; 45(2):87-91. PubMed ID: 19232270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CT guided percutaneous needle biopsy of mediastinal lymph nodes for staging of primary lung carcinoma].
    Akamatsu H; Amano J; Suzuki A; Kikushima Y
    Kyobu Geka; 1994 Jun; 47(6):462-5. PubMed ID: 8207886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.